Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Wilson's Disease Market: Emerging Therapies to Boost Growth in Future Years - Research and Markets

Research and Markets
Posted on: 15 Sep 16

Research and Markets has announced the addition of the "Global Wilson's Disease Market: Industry Analysis & Outlook" report to their offering.

Wilson's disease is a rare, congenital disorder which is also known as hepatolenticular degeneration and is named after Kinnear Wilson who was the first to describe this disorder in 1912. Wilson's disease is an inherited condition that leads to excessive accumulation of copper in vital organs such as the liver, brain, etc.

Wilson's disease is caused by the alteration of a gene named ATP7B. This mutation prevents the liver from disposing of the accumulated copper from the body as a healthy liver should. Eventually, copper is released into the bloodstream and it gets deposited in other organs, especially the brain, kidneys, and cornea. When diagnosed early, Wilson's disease is treatable. Even though the treatment is life-long, if patients stay on drugs and are compliant to it, they can basically experience a normal life expectancy.

The major factors that are expected to drive the market include rising prices of chelators in the US, rising attractiveness of orphan drugs market, increasing global healthcare expenditure as well as spending on medicines. The significant trends in the market comprise falling number of prescriptions for Wilson's disease, and the development of gene therapy as a potential cure for the disease. However, the market is threatened by critical challenges such as under-diagnosis of the disease, lack of safety in treatments, poor compliance to current treatments and unmet efficacy needs.

The research report provides a comprehensive study of global Wilson's disease market performance at present and future outlook and also an in-depth study of its major regional markets such as those in Europe and the US. Furthermore, market dynamics such as key trends and development; and challenges are examined in depth.

Companies Mentioned:

  • Meda AB
  • Teva Pharmaceuticals
  • Valeant Pharmaceuticals Inc.
  • Wilson Therapeutics

Key Topics Covered:

1. Market Overview

2. Global Market

3. Regional Markets

4. Market Dynamics

5. Competitive Landscape

6. Company Profiles

For more information about this report visit

Related Topics: Central Nervous System Drugs

View source version on

Business Wire

Last updated on: 15/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.